UB-165 fumarate is used as a nicotinic acetylcholine receptor (nAChR) agonist for studying receptor subtype selectivity and function; it acts as a full agonist at the α3β2 nAChR subtype and a partial agonist at the α4β2* subtype, and is employed in vitro to stimulate dopamine release from striatal synaptosomes for neuropharmacological research.